📰 Inter Partes News
Page 2 - Inter Partes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inter Partes. Real-time updates on events, politics, business and more.
February 1, 2023
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a "listening session" focusing on USPTO-FDA collaboration initiatives proposed...
January 25, 2023
25.01.2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia) announces that the Patent Trial and Appeal Board (PTAB) of the United States’ Patent and Trademark Office has terminated the Inter Partes Review (IPR) it had instituted with respect to Aurinia’s ...
December 29, 2022
My practice focuses on patent disputes before district courts, the ITC and the PTAB. I began practicing in 2011 and have had the opportunity to work on cases involving a variety of technologies...
October 7, 2022
Under the Administrative Procedure Act, the Patent Trial and Appeal Board must fully and particularly set out the basis upon which it reached its decision. In Provisur Technologies Inc. v. Weber, the Federal Circuit found that the Board failed to meet this standard.
September 30, 2022
Patent Trademark Office PTO replace four legacy tools—Public-Examiner’s Automated Search Tool, Public-Web-Based Examiner’s Search Tool, Patent Full-Text and Image Database PatFT and Patent Application Full-Text and Image Database AppFT with new Patent Public Search Tool PPUBS.
September 29, 2022
The US Patent & Trademark Office (PTO) will replace four legacy tools—Public-Examiner’s Automated Search Tool, Public-Web-Based Examiner’s Search Tool, Patent Full-Text and Image...
September 8, 2022
On August 31, 2022, the PTAB instituted two inter partes reviews of Chugai and Roche's tocilizumab patents challenged by Celltrion, adding to the growing list of IPRs instituted against the tocilizumab patent estate.
September 2, 2022
Law firm BakerHostetler has hired Duane Carver as counsel in Dallas and Kyle Morse as counsel in New York, and both will be members of the firm’s electrical, mechanical and computer science prosecution team.
August 4, 2022
04.08.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the second quarter ended June 30, 2022. Amounts, unless specified otherwise, are expressed in U.S. dollars. Second Quarter 2022 and Recent ...
August 2, 2022
In this episode, we welcome Roger Wylie, the Managing Partner of Kilpatrick Townsend & Stockton. Roger was the Co-Managing Partner of Townsend and Townsend and Crew prior to its merger...